Codexis (CDXS) and Nitto Denko (NDEKY) Avecia (NDEKY0 announced that they have entered into an evaluation agreement. Under the terms of the agreement, Nitto Denko Avecia will evaluate Codexis’ ECO Synthesis Manufacturing Platform. The collaboration will pave the way for licensing discussions and broader adoption of the ECO Synthesis platform, which replaces traditional solid-phase oligonucleotide synthesis with a flexible, enzyme-catalyzed approach built to scale.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CDXS:
